🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this randomized study is to determine the safety and efficac...
Status
Recruiting
Location
Valkyrie Clinical Trials
Start Date
2021-09-03
Trial ID
NCT04486833
Treatments Being Tested
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
Clinical study to investigate the efficacy and safety of savolitinib in com...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-08-03
Trial ID
NCT05261399
Treatments Being Tested
Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-06-25
Trial ID
NCT03944772
This study aimed to evaluate the anticancer activity of capmatinib in combi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2021-09-22
Trial ID
NCT04816214
Treatments Being Tested
Lung cancer still occupies the highest incidence and mortality rate in the ...
Status
Unknown
Location
Fudan University shanghai cancer center
Start Date
2020-11-01
Trial ID
NCT04517526
Treatments Being Tested
The purpose of this study is to measure efficacy and safety of osimertinib ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2024-04-21
Trial ID
NCT06194448
Treatments Being Tested
This phase III trial compares the effect of adding stereotactic body radiat...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-07-12
Trial ID
NCT05624996
This study is a Phase III, international, multicenter, randomized, controll...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-09-26
Trial ID
NCT06970639
The study will evaluate the efficacy and safety of treatment with chemother...
Status
Active Not Recruiting
Location
Research Site
Start Date
2021-09-12
Trial ID
NCT04765059